Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Voluntary Financial Disclosure Guidelines Being Considered By PhRMA

Executive Summary

PhRMA is considering the development of voluntary guidelines on financial interest disclosure for researchers publishing study results as part of a strategy to improve the pharmaceutical industry's image in a climate in which questions have arisen about investigator-sponsor relationships.

You may also be interested in...



BIO Wants Waxman/Hatch Reform Isolated From Generic Biologics

BIO hopes that jurisdictional considerations will prevent the Senate Judiciary Committee's discussion of Waxman/Hatch revisions from becoming a forum for arguments over an FDA approval process for generic versions of biological products.

BIO Wants Waxman/Hatch Reform Isolated From Generic Biologics

BIO hopes that jurisdictional considerations will prevent the Senate Judiciary Committee's discussion of Waxman/Hatch revisions from becoming a forum for arguments over an FDA approval process for generic versions of biological products.

Pharmacoeconomic Analysis Methods Should Be Standardized - JAMA

Standardized methods of pharmacoeconomic analysis should be developed to better enable study comparisons, Sheldon Krimsky, PhD, Tufts University, advocated in an Oct. 20 Journal of the American Medical Association editorial.

Related Content

UsernamePublicRestriction

Register

PS035184

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel